Kiniksa Pharmaceuticals International Plc (KNSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Operating Expenses | 39,289 | 67,647 | 44,134 | 26,159 | 21,527 |
| Operating Income | -39,289 | -67,647 | -44,134 | -26,159 | -21,527 |
| Other Income | 1,724 | 1,809 | 1,726 | 1,622 | 1,066 |
| Pre-tax Income | -37,565 | -65,838 | -42,408 | -24,537 | -20,461 |
| Income Tax | -374 | -17 | 172 | -131 | -202 |
| Net Income Continuous | -37,191 | -65,821 | -42,580 | -24,406 | -20,259 |
| Net Income | $-37,191 | $-65,821 | $-42,580 | $-24,406 | $-20,259 |
| EPS Basic Total Ops | -0.68 | -1.27 | 4.58 | -0.51 | -1.11 |
| EPS Basic Continuous Ops | -0.68 | -1.27 | 4.57 | -0.51 | -1.11 |
| EPS Diluted Total Ops | -0.68 | -1.27 | 4.58 | -0.51 | -1.11 |
| EPS Diluted Continuous Ops | -0.68 | -1.27 | 4.57 | -0.51 | -1.11 |
| EBITDA(a) | $-38,781 | $-67,176 | $-43,880 | $-26,147 | $-21,515 |